A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
Recruiting · NCT06720987 · Registry updated 2026-04-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 1 | 2026-04-23 | NCT06720987 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Kumquat Biosciences Inc. | 7 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cleveland Clinic, Taussig Cancer Institute | Cleveland | United States | 2 |
| Dana Farber Cancer Institute | Boston | United States | 300 |
| Mayo Clinic, Jacksonville | Jacksonville | United States | 7 |
| Mayo Clinic, Phoenix | Phoenix | United States | 1 |
| Mayo Clinic, Rochester | Rochester | United States | 17 |
| NEXT Oncology | San Antonio | United States | 70 |
| NEXT Virginia, LLC | Fairfax | United States | 1 |
| OU Health Stephenson Cancer Center | Oklahoma City | United States | 23 |
| Sarah Cannon Cancer Institute at HealthONE | Denver | United States | 2 |
| START Midwest | Grand Rapids | United States | 79 |
| Sydney Kimmel Cancer Center | Philadelphia | United States | 1 |